News from our business units
New regulatory requirements are increasing the demands placed on digital sovereignty. Resilience is becoming mandatory.
AI in the regulated GxP environment: Dr Hans Klöcker explains how pharmaceutical companies validate AI solutions and ensure safe, compliant operation.
Transformation Insights
New regulatory requirements are increasing the demands placed on digital sovereignty. Resilience is becoming mandatory.
AI in the regulated GxP environment: Dr Hans Klöcker explains how pharmaceutical companies validate AI solutions and ensure safe, compliant operation.
Neue Artikel
NIS2 makes resilience in the pharmaceutical industry a strategic leadership priority, requiring an integrated operating model that harmonizes compliance, cybersecurity, and business continuity.
Bei der Einführung von künstlicher Intelligenz in Unternehmen steht die Funktionalität oft im Vordergrund; Fragen der digitalen Souveränität bleiben nachgelagert. Dabei greift kaum eine Technologie so tief in Daten, Prozesse und Infrastruktur ein wie KI.